Literature DB >> 21153212

Identification of two distinct Sp1- and RBF-1-like nuclear factors that bind to the upstream region of the human angiotensinogen promoter.

S Shimada1, K Yanai, S Takahashi, K Murakami, A Fukamizu.   

Abstract

Angiotensionogen, the protein precursor of angiotensin II that is a crucial regulator of blood pressure and electrolyte balance, is constitutively produced by the liver. In the present study, we identified two nuclear factors that are possibly involved in maintaining the constitutive promoter activity of the human angiotensinogen gene. The 32 bp DNA region between -344 and -313 located in the 1.3 kb angiotensinogen upstream region (-1222 to +44) partially contributed to the maintenance of the efficient promoter activity in HepG2 cells. This segment was able to form the complexes with HepG2 nuclear extracts, which could be dissociated by competing recognition sequences that contain those of either Sp1 or RBF-1. Anin vivo competition experiment demonstrated that the parental promoter activity is reduced about 65% by an RBF-1 competitor more effectively than by an Sp1 competitor. These results suggested that Sp1- and RBF-1-like factors play roles in maintaining the constitutively active angiotensinogen promoter.

Entities:  

Year:  1995        PMID: 21153212     DOI: 10.1007/BF02738831

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  32 in total

1.  Cloning by recognition site screening of two novel GT box binding proteins: a family of Sp1 related genes.

Authors:  G Hagen; S Müller; M Beato; G Suske
Journal:  Nucleic Acids Res       Date:  1992-11-11       Impact factor: 16.971

2.  Structure and expression of the human angiotensinogen gene. Identification of a unique and highly active promoter.

Authors:  A Fukamizu; S Takahashi; M S Seo; M Tada; K Tanimoto; S Uehara; K Murakami
Journal:  J Biol Chem       Date:  1990-05-05       Impact factor: 5.157

3.  Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism.

Authors:  E Pascal; R Tjian
Journal:  Genes Dev       Date:  1991-09       Impact factor: 11.361

4.  Multiple hepatocyte-enriched nuclear factors function in the regulation of transthyretin and alpha 1-antitrypsin genes.

Authors:  R H Costa; D R Grayson; J E Darnell
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

5.  Purification and biochemical characterization of the promoter-specific transcription factor, Sp1.

Authors:  M R Briggs; J T Kadonaga; S P Bell; R Tjian
Journal:  Science       Date:  1986-10-03       Impact factor: 47.728

6.  cDNA cloning and transcriptional properties of a novel GC box-binding protein, BTEB2.

Authors:  K Sogawa; H Imataka; Y Yamasaki; H Kusume; H Abe; Y Fujii-Kuriyama
Journal:  Nucleic Acids Res       Date:  1993-04-11       Impact factor: 16.971

7.  A cell type-dependent enhancer core element is located in exon 5 of the human angiotensinogen gene.

Authors:  Y Nibu; K Tanimoto; S Takahashi; H Ono; K Murakami; A Fukamizu
Journal:  Biochem Biophys Res Commun       Date:  1994-12-15       Impact factor: 3.575

8.  Identification of cell type-dependent enhancer core element located in the 3'-downstream region of the human angiotensinogen gene.

Authors:  Y Nibu; S Takahashi; K Tanimoto; K Murakami; A Fukamizu
Journal:  J Biol Chem       Date:  1994-11-18       Impact factor: 5.157

9.  Identification of cis-acting DNA elements involved in the regulation of angiotensinogen gene expression.

Authors:  Y Y Zhao; W Gu; M A Siddiqui; A Kumar
Journal:  Cell Mol Biol       Date:  1992-02       Impact factor: 1.770

10.  Muscle-specific expression of the cardiac alpha-actin gene requires MyoD1, CArG-box binding factor, and Sp1.

Authors:  V Sartorelli; K A Webster; L Kedes
Journal:  Genes Dev       Date:  1990-10       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.